NewEdge Wealth LLC Sells 10,496 Shares of CVS Health Corporation $CVS

Posted by Francis Steltz on Jul 28th, 2026

NewEdge Wealth LLC trimmed its position in CVS Health Corporation (NYSE:CVS – Free Report) by 41.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,603 shares of the pharmacy operator’s stock after selling 10,496 shares during the quarter. NewEdge Wealth LLC’s holdings in CVS Health were worth $1,049,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Arvest Bank Trust Division increased its position in CVS Health by 2,401.7% during the 1st quarter. Arvest Bank Trust Division now owns 66,945 shares of the pharmacy operator’s stock valued at $4,808,000 after purchasing an additional 64,269 shares during the period. Daner Wealth Management LLC purchased a new stake in shares of CVS Health in the 1st quarter worth approximately $194,000. First Citizens Bank & Trust Co. boosted its stake in shares of CVS Health by 6.3% during the first quarter. First Citizens Bank & Trust Co. now owns 38,038 shares of the pharmacy operator’s stock valued at $2,732,000 after purchasing an additional 2,266 shares in the last quarter. CI Investments Inc. increased its holdings in CVS Health by 10.1% during the first quarter. CI Investments Inc. now owns 106,462 shares of the pharmacy operator’s stock valued at $7,646,000 after buying an additional 9,736 shares during the period. Finally, First Trust Advisors LP raised its stake in CVS Health by 4.2% in the first quarter. First Trust Advisors LP now owns 2,344,647 shares of the pharmacy operator’s stock worth $168,393,000 after buying an additional 93,502 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Price Performance

NYSE CVS opened at $107.05 on Tuesday. The firm’s fifty day simple moving average is $100.43 and its two-hundred day simple moving average is $86.35. The firm has a market capitalization of $136.59 billion, a P/E ratio of 47.16, a P/E/G ratio of 1.05 and a beta of 0.61. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78. CVS Health Corporation has a 12-month low of $58.99 and a 12-month high of $110.68.

CVS Health (NYSE:CVS – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating the consensus estimate of $2.21 by $0.36. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.The firm had revenue of $100.43 billion during the quarter, compared to analyst estimates of $94.99 billion. During the same quarter in the prior year, the business posted $2.25 EPS. The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. Analysts forecast that CVS Health Corporation will post 7.46 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, August 3rd. Shareholders of record on Thursday, July 23rd will be issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.5%. The ex-dividend date of this dividend is Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is currently 117.18%.

Insider Transactions at CVS Health

In other news, EVP Tilak Mandadi sold 69,551 shares of CVS Health stock in a transaction on Friday, May 8th. The shares were sold at an average price of $89.58, for a total transaction of $6,230,378.58. Following the completion of the sale, the executive vice president directly owned 10,133 shares in the company, valued at approximately $907,714.14. The trade was a 87.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Larry Robbins sold 370,462 shares of the firm’s stock in a transaction on Thursday, May 21st. The stock was sold at an average price of $93.45, for a total value of $34,619,673.90. Following the completion of the transaction, the director owned 4,824,799 shares of the company’s stock, valued at $450,877,466.55. This trade represents a 7.13% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 3,441,551 shares of company stock worth $323,703,977 in the last 90 days. Insiders own 0.85% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on CVS. Weiss Ratings upgraded CVS Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, July 20th. DA Davidson boosted their price target on CVS Health from $80.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. TD Cowen raised their price objective on CVS Health from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Cantor Fitzgerald lifted their target price on CVS Health from $100.00 to $110.00 and gave the company an “overweight” rating in a research note on Tuesday, July 7th. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Twenty-one investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $105.67.

Check Out Our Latest Report on CVS Health

About CVS Health

(Free Report)

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.